Volume 5 Issue 5 Articles

Keywords

Anesthesiology Case Reports

Cardiology Case Reports

Dentistry Case Reports

Diabetology Case Reports

Gastroenterology Case Reports

Otolaryngology Case Reports

Volume 5 Issue 5 Articles

Presenting with polydipsia and polyuria and diagnosed with central diabetes insipidus, the 75-year-old woman had a 5-year history of controlled type 2 diabetes mellitus.

A rare condition known as central diabetes insipidus (or CDI) is characterized by excessively diluted urine due to a deficiency in antidiuretic hormone. It is uncommon for diabetes mellitus and CDI to coexist without hereditary conditions like Wolfram syndrome. Diagnosing this combination of illnesses is crucial but also difficult because thirst, polydipsia, and polyuria are the symptoms of both conditions.

PDF FullText DOI: 10.52338/cicaserep.2023.1071

Is safety a concern when using blinatumomab therapy for COVID-19 infection?

SARS-CoV-2 infection and serious sickness may be more likely to strike patients with acute lymphoblastic leukemia. For patients with refractory or relapsed B-cell precursor acute lymphoblastic leukemia, blinatumomab is the cornerstone of current treatment. We report on a patient who developed a positive SARS-CoV-2 test while receiving blinatumomab therapy for relapsed acute lymphoblastic leukemia. Regarding the choice of whether to keep these patients on blinatumomab treatment or to stop it altogether, there are no official guidelines.

PDF FullText DOI: 10.52338/cicaserep.2023.1070